TIMP2 and acute kidney injury: Interestingly, a recently published secondary analysis of the Sapphire study revealed that a single measurement of [TIMP-2]•[IGFBP7] early in the setting of critical illness is able to identify adult patients with AKI at increased risk for mortality or receipt of RRT over the subsequent 9 months [24].